COMPOUNDS THAT ARE ERK INHIBITORS
Disclosed are the ERK inhibitors of formula 1.0: and the pharmaceutically acceptable salts, and solvates thereof. Q is a tetrahydropyridinyl ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ZHU HUGH Y PATEL MEHUL F KELLY JOSEPH M NAN YANG DENG YONGQI WANG JAMES J-S PALIWAL SUNIL DESAI JAGDISH A ALHASSAN ABDUL-BASIT DOLL RONALD J SHIH NENG-YANG YAO XIN ZHU LIANG COOPER ALAN B GAO XIAOLEI TSUI HONUNG SHIPPS JR GERALD W BOGA SOBHANA BABU GUDIPATI SUBRAHMANYAM |
| description | Disclosed are the ERK inhibitors of formula 1.0: and the pharmaceutically acceptable salts, and solvates thereof. Q is a tetrahydropyridinyl ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA201005909B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA201005909B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA201005909B3</originalsourceid><addsrcrecordid>eNrjZFB09vcN8A_1cwlWCPFwDFFwDHJVcA3yVvD08_B08gzxDwrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxUY5GBoYGBqaWBpZOxsSoAQAWLyIw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOUNDS THAT ARE ERK INHIBITORS</title><source>esp@cenet</source><creator>ZHU HUGH Y ; PATEL MEHUL F ; KELLY JOSEPH M ; NAN YANG ; DENG YONGQI ; WANG JAMES J-S ; PALIWAL SUNIL ; DESAI JAGDISH A ; ALHASSAN ABDUL-BASIT ; DOLL RONALD J ; SHIH NENG-YANG ; YAO XIN ; ZHU LIANG ; COOPER ALAN B ; GAO XIAOLEI ; TSUI HONUNG ; SHIPPS JR GERALD W ; BOGA SOBHANA BABU ; GUDIPATI SUBRAHMANYAM</creator><creatorcontrib>ZHU HUGH Y ; PATEL MEHUL F ; KELLY JOSEPH M ; NAN YANG ; DENG YONGQI ; WANG JAMES J-S ; PALIWAL SUNIL ; DESAI JAGDISH A ; ALHASSAN ABDUL-BASIT ; DOLL RONALD J ; SHIH NENG-YANG ; YAO XIN ; ZHU LIANG ; COOPER ALAN B ; GAO XIAOLEI ; TSUI HONUNG ; SHIPPS JR GERALD W ; BOGA SOBHANA BABU ; GUDIPATI SUBRAHMANYAM</creatorcontrib><description>Disclosed are the ERK inhibitors of formula 1.0: and the pharmaceutically acceptable salts, and solvates thereof. Q is a tetrahydropyridinyl ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140326&DB=EPODOC&CC=ZA&NR=201005909B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140326&DB=EPODOC&CC=ZA&NR=201005909B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHU HUGH Y</creatorcontrib><creatorcontrib>PATEL MEHUL F</creatorcontrib><creatorcontrib>KELLY JOSEPH M</creatorcontrib><creatorcontrib>NAN YANG</creatorcontrib><creatorcontrib>DENG YONGQI</creatorcontrib><creatorcontrib>WANG JAMES J-S</creatorcontrib><creatorcontrib>PALIWAL SUNIL</creatorcontrib><creatorcontrib>DESAI JAGDISH A</creatorcontrib><creatorcontrib>ALHASSAN ABDUL-BASIT</creatorcontrib><creatorcontrib>DOLL RONALD J</creatorcontrib><creatorcontrib>SHIH NENG-YANG</creatorcontrib><creatorcontrib>YAO XIN</creatorcontrib><creatorcontrib>ZHU LIANG</creatorcontrib><creatorcontrib>COOPER ALAN B</creatorcontrib><creatorcontrib>GAO XIAOLEI</creatorcontrib><creatorcontrib>TSUI HONUNG</creatorcontrib><creatorcontrib>SHIPPS JR GERALD W</creatorcontrib><creatorcontrib>BOGA SOBHANA BABU</creatorcontrib><creatorcontrib>GUDIPATI SUBRAHMANYAM</creatorcontrib><title>COMPOUNDS THAT ARE ERK INHIBITORS</title><description>Disclosed are the ERK inhibitors of formula 1.0: and the pharmaceutically acceptable salts, and solvates thereof. Q is a tetrahydropyridinyl ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB09vcN8A_1cwlWCPFwDFFwDHJVcA3yVvD08_B08gzxDwrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxUY5GBoYGBqaWBpZOxsSoAQAWLyIw</recordid><startdate>20140326</startdate><enddate>20140326</enddate><creator>ZHU HUGH Y</creator><creator>PATEL MEHUL F</creator><creator>KELLY JOSEPH M</creator><creator>NAN YANG</creator><creator>DENG YONGQI</creator><creator>WANG JAMES J-S</creator><creator>PALIWAL SUNIL</creator><creator>DESAI JAGDISH A</creator><creator>ALHASSAN ABDUL-BASIT</creator><creator>DOLL RONALD J</creator><creator>SHIH NENG-YANG</creator><creator>YAO XIN</creator><creator>ZHU LIANG</creator><creator>COOPER ALAN B</creator><creator>GAO XIAOLEI</creator><creator>TSUI HONUNG</creator><creator>SHIPPS JR GERALD W</creator><creator>BOGA SOBHANA BABU</creator><creator>GUDIPATI SUBRAHMANYAM</creator><scope>EVB</scope></search><sort><creationdate>20140326</creationdate><title>COMPOUNDS THAT ARE ERK INHIBITORS</title><author>ZHU HUGH Y ; PATEL MEHUL F ; KELLY JOSEPH M ; NAN YANG ; DENG YONGQI ; WANG JAMES J-S ; PALIWAL SUNIL ; DESAI JAGDISH A ; ALHASSAN ABDUL-BASIT ; DOLL RONALD J ; SHIH NENG-YANG ; YAO XIN ; ZHU LIANG ; COOPER ALAN B ; GAO XIAOLEI ; TSUI HONUNG ; SHIPPS JR GERALD W ; BOGA SOBHANA BABU ; GUDIPATI SUBRAHMANYAM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA201005909B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHU HUGH Y</creatorcontrib><creatorcontrib>PATEL MEHUL F</creatorcontrib><creatorcontrib>KELLY JOSEPH M</creatorcontrib><creatorcontrib>NAN YANG</creatorcontrib><creatorcontrib>DENG YONGQI</creatorcontrib><creatorcontrib>WANG JAMES J-S</creatorcontrib><creatorcontrib>PALIWAL SUNIL</creatorcontrib><creatorcontrib>DESAI JAGDISH A</creatorcontrib><creatorcontrib>ALHASSAN ABDUL-BASIT</creatorcontrib><creatorcontrib>DOLL RONALD J</creatorcontrib><creatorcontrib>SHIH NENG-YANG</creatorcontrib><creatorcontrib>YAO XIN</creatorcontrib><creatorcontrib>ZHU LIANG</creatorcontrib><creatorcontrib>COOPER ALAN B</creatorcontrib><creatorcontrib>GAO XIAOLEI</creatorcontrib><creatorcontrib>TSUI HONUNG</creatorcontrib><creatorcontrib>SHIPPS JR GERALD W</creatorcontrib><creatorcontrib>BOGA SOBHANA BABU</creatorcontrib><creatorcontrib>GUDIPATI SUBRAHMANYAM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHU HUGH Y</au><au>PATEL MEHUL F</au><au>KELLY JOSEPH M</au><au>NAN YANG</au><au>DENG YONGQI</au><au>WANG JAMES J-S</au><au>PALIWAL SUNIL</au><au>DESAI JAGDISH A</au><au>ALHASSAN ABDUL-BASIT</au><au>DOLL RONALD J</au><au>SHIH NENG-YANG</au><au>YAO XIN</au><au>ZHU LIANG</au><au>COOPER ALAN B</au><au>GAO XIAOLEI</au><au>TSUI HONUNG</au><au>SHIPPS JR GERALD W</au><au>BOGA SOBHANA BABU</au><au>GUDIPATI SUBRAHMANYAM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOUNDS THAT ARE ERK INHIBITORS</title><date>2014-03-26</date><risdate>2014</risdate><abstract>Disclosed are the ERK inhibitors of formula 1.0: and the pharmaceutically acceptable salts, and solvates thereof. Q is a tetrahydropyridinyl ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_ZA201005909B |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | COMPOUNDS THAT ARE ERK INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T14%3A09%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHU%20HUGH%20Y&rft.date=2014-03-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA201005909B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |